Khepri Pharmaceuticals Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$33.4M
Khepri Pharmaceuticals General Information
Description
Developer of therapeutic products based on proteases and protease inhibitors. The company is a biopharmaceutical company which developes proteases and their inhibitors as therapeutics.
Contact Information
Corporate Office
- 385 Oyster Point Boulevard
- Suite 3
- South San Francisco, CA 94080
- United States
Corporate Office
- 385 Oyster Point Boulevard
- Suite 3
- South San Francisco, CA 94080
- United States
Khepri Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 26-Dec-1995 | $33.4M | Completed | Product Development | ||
| 3. Early Stage VC | 10-Nov-1994 | Completed | Product Development | |||
| 2. Early Stage VC | 08-Jan-1993 | $6.8M | $11.8M | Completed | Product Development | |
| 1. Early Stage VC | 01-Jan-1994 | $5M | $5M | Completed | Product Development |
Khepri Pharmaceuticals Patents
Khepri Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-1996013523-A1 | Cathepsin o2 protease | Inactive | 27-Oct-1994 | ||
| US-20030175937-A1 | Proteins; nucleic acid; antibodies; bone remodeling | Inactive | 27-Oct-1994 | ||
| WO-1995023222-A1 | Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups | Inactive | 25-Feb-1994 | C07D295/215 |
Khepri Pharmaceuticals Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Brentwood Associates | PE/Buyout | Minority | ||
| CHL Medical Partners | Venture Capital | Minority | ||
| Genentech | Corporation | Minority | ||
| Kleiner Perkins | Venture Capital | Minority |
Khepri Pharmaceuticals FAQs
-
When was Khepri Pharmaceuticals founded?
Khepri Pharmaceuticals was founded in 1992.
-
Where is Khepri Pharmaceuticals headquartered?
Khepri Pharmaceuticals is headquartered in South San Francisco, CA.
-
What industry is Khepri Pharmaceuticals in?
Khepri Pharmaceuticals’s primary industry is Biotechnology.
-
Is Khepri Pharmaceuticals a private or public company?
Khepri Pharmaceuticals is a Private company.
-
What is the current valuation of Khepri Pharmaceuticals?
The current valuation of Khepri Pharmaceuticals is .
-
What is Khepri Pharmaceuticals’s current revenue?
The current revenue for Khepri Pharmaceuticals is .
-
How much funding has Khepri Pharmaceuticals raised over time?
Khepri Pharmaceuticals has raised $22.8M.
-
Who are Khepri Pharmaceuticals’s investors?
Abingworth, Brentwood Associates, CHL Medical Partners, Genentech, and Kleiner Perkins are 5 of 12 investors who have invested in Khepri Pharmaceuticals.
-
When was Khepri Pharmaceuticals acquired?
Khepri Pharmaceuticals was acquired on 26-Dec-1995.
-
Who acquired Khepri Pharmaceuticals?
Khepri Pharmaceuticals was acquired by AXYS Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process